CVS announced it will split into two separate public companies by mid-2028: one focusing on healthcare solutions and the other on retail pharmacy. This move caused CVS shares to drop over 11% despite strong earnings. The split will affect healthcare sector ETFs, dividend funds, and S&P 500 index funds that hold CVS shares, as they will receive shares in both new companies. Investors should watch for updates on financial details, index reclassification, and CVS's earnings outlook before the split completes.
CVS shares have dropped significantly, with a 1-day change of -12.44% on Pluang, reflecting market reaction to the announced split. The stock is currently priced at USD 80.03 with a dividend yield of 2.91%. These figures are as of Nov 04, 2026 23:51 WIB.
CVS Health announced plans to split into two publicly traded companies by 2028. One company will combine Aetna, its health insurance arm, with the pharmacy benefits business, while the other will focus on operating CVS Pharmacy's retail stores and ph...
CVS Health is reportedly considering splitting into two publicly traded companies, separating its retail drugstores from its insurance and pharmacy benefit management units, including Aetna and Caremark. This move could reverse the 2018 Aetna acquisi...
CVS Health announced plans to split into two separate public companies by mid-2028, undoing its $78 billion acquisition of insurer Aetna and breaking up its integrated healthcare business. The split will separate CVS's 9,000 retail pharmacies from it...
CVS Health announced plans to separate into two independent publicly traded companies by the first half of 2028. One company will focus on healthcare solutions, including Aetna and CVS Caremark, while the other will be a retail pharmacy company with ...
CVS Health reported a 5.4% increase in third-quarter revenues to $108.4 billion, driven by growth in its Health Services and Health Care Benefits segments. GAAP diluted EPS improved to $1.68 from a loss of $3.13 last year, while adjusted EPS rose to ...
